The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2015

Filed:

Mar. 06, 2012
Applicants:

Kazuaki Ishihara, Nagoya, JP;

Muhammet Uyanik, Nagoya, JP;

Takeshi Yasui, Nagoya, JP;

Inventors:

Kazuaki Ishihara, Nagoya, JP;

Muhammet Uyanik, Nagoya, JP;

Takeshi Yasui, Nagoya, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 307/94 (2006.01); C07D 491/107 (2006.01); C07D 317/72 (2006.01); C07C 217/20 (2006.01); C07C 311/17 (2006.01); C07C 233/69 (2006.01); C07C 233/70 (2006.01); C07C 271/16 (2006.01); B01J 31/02 (2006.01); C07C 235/48 (2006.01);
U.S. Cl.
CPC ...
B01J 31/0209 (2013.01); C07C 217/20 (2013.01); C07C 233/69 (2013.01); C07C 233/70 (2013.01); C07C 235/48 (2013.01); C07C 271/16 (2013.01); C07C 311/17 (2013.01); C07D 307/94 (2013.01); C07D 317/72 (2013.01); C07D 491/107 (2013.01);
Abstract

An optically active spirolactone compound is highly enantioselectively produced by using an iodoarene derivative which can be synthesized easily and which is not racemized easily. A hypervalent iodine compound precursor (iodoarene derivative) which was able to be designed flexibly was synthesized from 2,6-dihydroxyiodoarene by using 1,2-aminoalcohol as a chiral source in short steps, a hypervalent iodine compound was prepared in a reaction system (in situ) by using a catalyst quantity of the resulting precursor in the presence of a stoichiometric quantity of m-CPBA, and a spirolactonization reaction of 3-(1-hydroxy-2-naphthyl)propionic acid was induced. As a result, a corresponding spirolactone compound was obtained at a high enantiomeric excess.


Find Patent Forward Citations

Loading…